Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Burkitt Lymphoma 34Lymphoma 30Leukemia 23Lymphoma, Non-Hodgkin 19Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Mantle-Cell 16Lymphoma, Large B-Cell, Diffuse 15Hodgkin Disease 13Waldenstrom Macroglobulinemia 11Recurrence 10Lymphoma, Follicular 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Biphenotypic, Acute 10Multiple Myeloma 9Lymphoma, T-Cell, Cutaneous 6Lymphoma, B-Cell 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, T-Cell 5Blast Crisis 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myelomonocytic, Chronic 4Neoplasms 3Nausea 3Lymphoma, T-Cell, Peripheral 3

Interventions

dacetuzumab 2Bortezomib 2epratuzumab 1Vorinostat 1Ultrasonography 1Tinzaparin 1Lenalidomide 1Dexamethasone 1Calcium Dobesilate 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemostatic Disorders × Calcium Dobesilate × Lymphoid × Clear all
NCT00525447 2014-10-09

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Seagen Inc.

Phase 1 Completed
36 enrolled
LymphoidPlasma cell

Blood Coagulation Disorders, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡